Atlas Trials

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Clinical trial NCT04906382 · TERMINATED

Trial details

NCT number
NCT04906382
Sponsor
Floor Backes, MD
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Lynch SyndromeRecurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Uterine Corpus CarcinosarcomaMismatch Repair DeficiencyRecurrent Endometrial CancerMetastatic Endometrial Cancer
Start date
2021-07-01
Primary completion
2022-09-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.